牙周炎治疗中全身抗菌药物辅助疗效的系统综述与Meta分析
该系统综述与Meta分析纳入28项至少随访6个月的随机临床试验,评估牙周炎患者接受龈下清创联合全身抗菌药物对比安慰剂的疗效。结果显示,全身抗菌药物辅助治疗在探诊深度、临床附着水平、探诊出血、袋闭合及残余袋频率方面均有统计学显著获益,但不良事件报告更频繁。最佳结局见于阿莫西林联合甲硝唑,其次为单用甲硝唑和阿奇霉素。
要点
- 全身抗菌药物辅助龈下清创在6个月以上随访中显著改善探诊深度等临床指标。
- 阿莫西林联合甲硝唑方案疗效最佳,其次为单用甲硝唑和阿奇霉素。
- 使用全身抗菌药物的组别不良事件报告更频繁。
核心结论
- 牙周炎治疗中辅助使用全身抗菌药物在临床结局上产生统计学显著获益,但试验组不良事件更频繁。
研究设计与样本
- 系统综述与Meta分析,纳入34篇文章(28项研究),为至少随访6个月的随机临床试验。
主要发现
- 短期研究探诊深度加权均数差WMD=0.448,95%CI[0.324;0.573],预测区间[-0.10 to 0.99],p<.001。
- 长期研究探诊深度WMD=0.485,95%CI[0.322;0.648],预测区间[-0.11 to 1.08],p<.001。
- 临床附着水平、探诊出血、袋闭合及残余袋频率也显示统计学显著获益。
- 最佳结局见于阿莫西林联合甲硝唑,其次为单用甲硝唑和阿奇霉素。
- 使用全身抗菌药物的组别不良事件报告更频繁。
关键数值与推荐
- 短期研究探诊深度WMD=0.448,95%CI[0.324;0.573],预测区间[-0.10 to 0.99],p<.001。
- 长期研究探诊深度WMD=0.485,95%CI[0.322;0.648],预测区间[-0.11 to 1.08],p<.001。
- 阿莫西林联合甲硝唑方案疗效最佳,其次为单用甲硝唑和阿奇霉素。
临床怎么用
- 对于牙周炎患者,龈下清创可考虑辅助全身抗菌药物以改善探诊深度等临床指标。
- 选择抗菌药物时需权衡疗效与不良事件风险,阿莫西林联合甲硝唑方案疗效最佳。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To answer the following PICOS questions: in patients with periodontitis, which is the efficacy of adjunctive systemic antimicrobials, in comparison with subgingival debridement plus a placebo, in terms of probing pocket depth (PPD) reduction, in randomized clinical trials with at least 6 months of follow-up? MATERIAL AND METHODS: A systematic search was conducted: 34 articles (28 studies) were included. Data on clinical outcome variables changes were pooled and analysed using weighted mean differences (WMDs), 95% confidence intervals (CI) and prediction intervals (PIs), in case of significant heterogeneity. RESULTS: For PPD, statistically significant benefits (p < .001) were observed in short-term studies (WMD = 0.448, 95% CI [0.324; 0.573], PI [-0.10 to 0.99]) and long-term studies (WMD = 0.485, 95% CI [0.322; 0.648], PI [-0.11 to 1.08]). Additionally, statistically significant benefits were also found for clinical attachment level, bleeding on probing, pocket closure and frequency of residual pockets. The best outcomes were observed for the combination of amoxicillin plus metronidazole, followed by metronidazole alone and azithromycin. Adverse events were more frequently reported in groups using systemic antimicrobials. CONCLUSIONS: The adjunctive use of systemic antimicrobials in periodontal therapy results in statistically significant benefits in clinical outcomes, with more frequent adverse events in test groups using systemic antimicrobials.
引用
- Teughels W, Feres M, Oud V, et al. Adjunctive effect of systemic antimicrobials in periodontitis therapy: A systematic review and meta-analysis. J Clin Periodontol. 2020. PMID: 31994207. doi:10.1111/jcpe.13264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。